ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,182.96
-0.85%
Dow Jones
40,211.72
0.53%
Gold vs US Dollar
2,430.085
0.32%
Brent Oil
83.975
-0.43%
Bitcoin
63,669.41
-1.82%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Newellis Inc (NUWE)

  7. Newellis Inc (NUWE) News

Newellis (NUWE)

Newellis Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NUWE
DateTimeSourceHeadlineSymbolCompany
08/02/202422:19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NUWENewellis Inc
06/02/202414:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
06/02/202414:00GlobeNewswire Inc.New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid OverloadNASDAQ:NUWENewellis Inc
09/01/202422:30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:NUWENewellis Inc
08/01/202414:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
04/01/202421:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUWENewellis Inc
04/01/202420:05GlobeNewswire Inc.Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral CatheterNASDAQ:NUWENewellis Inc
13/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
28/11/202313:00GlobeNewswire Inc.New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric PatientsNASDAQ:NUWENewellis Inc
14/11/202321:30GlobeNewswire Inc.Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:NUWENewellis Inc
07/11/202315:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NUWENewellis Inc
07/11/202313:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
07/11/202313:00GlobeNewswire Inc.Nuwellis, Inc. Announces Third Quarter 2023 Financial ResultsNASDAQ:NUWENewellis Inc
01/11/202320:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
01/11/202312:00GlobeNewswire Inc.Nuwellis Announces Board of Directors TransitionNASDAQ:NUWENewellis Inc
31/10/202312:00GlobeNewswire Inc.Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic DeviceNASDAQ:NUWENewellis Inc
18/10/202321:15GlobeNewswire Inc.Nuwellis, Inc. To Announce Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:NUWENewellis Inc
17/10/202321:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
17/10/202321:15GlobeNewswire Inc.Nuwellis Announces Closing of $2.25 Million Public Offering of Series J Convertible Redeemable Preferred Stock and WarrantsNASDAQ:NUWENewellis Inc
13/10/202313:30GlobeNewswire Inc.Nuwellis Announces Pricing of $2.25 Million Public Offering of Series J Convertible Redeemable Preferred Stock and WarrantsNASDAQ:NUWENewellis Inc
10/10/202313:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
10/10/202313:00GlobeNewswire Inc.Nuwellis Provides Regulatory Update on SeaStar Medical’s Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under a Humanitarian Device ExemptionNASDAQ:NUWENewellis Inc
06/10/202321:50Edgar (US Regulatory)Form POS462C - Post-effective amendment to registration statement [Rule 462(c)]NASDAQ:NUWENewellis Inc
05/10/202314:27Edgar (US Regulatory)Form AW - Amendment Withdrawal RequestNASDAQ:NUWENewellis Inc
04/10/202322:29Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:NUWENewellis Inc
02/10/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NUWENewellis Inc
29/09/202313:56Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NUWENewellis Inc
11/09/202321:15GlobeNewswire Inc.Nuwellis to Present at the Gilmartin Group Emerging Growth ShowcaseNASDAQ:NUWENewellis Inc
06/09/202321:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUWENewellis Inc
06/09/202321:12Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NUWENewellis Inc
 Showing the most relevant articles for your search:NASDAQ:NUWE

Your Recent History

BIT
P1NIU5
BNP Paribas Issuance
NASDAQ
APTM
Alpha Partners Technolog...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved